Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
UG Healthcare Corporation Limited (8K7.SI)
Singapore, SG
UG Healthcare Corporation Limited, an investment holding company established in Singapore in 1989, primarily engages in the manufacturing and worldwide distribution of disposable gloves. Its business is structured across three main segments: Latex Examination Gloves, Nitrile Examination Gloves, and a category for Other Ancillary Products. The company's offerings include both latex examination gloves, available in single and double chlorinated polymer-coated varieties, as well as nitrile examination gloves. Additionally, it supplies a range of supplementary items like surgical gloves, vinyl and cleanroom disposable gloves, face masks, various other medical disposables, and protective shoe covers. The firm also extends its expertise through business and management consultancy services. Its products serve diverse sectors such as healthcare, food and beverage, industrial and high-technology manufacturing, automotive, research and development, and the beauty industry. Operating under its "Unigloves" brand name, the corporation reaches customers across Malaysia, Europe, North America, South America, Africa, and the broader Asian market.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.16% | +0.00% | +7.41% | -5.43% | -10.31% | -8.42% | -20.18% | -44.94% | -86.62% | -15.81% | +4.40% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%+25.1% ★ Q4'23: -57.6% (vs Q4'21)
-
EPS growth Medical - Instruments & Supplies: +16.3%+37.1% ★ Q4'23: -123.2% (vs Q4'21)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-5.4% Q4'23: -27.8% (vs Q4'21)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-0.9% Q4'23: -12.2% (vs Q4'21)
-
ROIC Medical - Instruments & Supplies: +6.0%-0.7% Q4'23: -13.0% (vs Q4'21)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.0% Q4'23: +1.2% (vs Q4'21)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×19.15× Q4'23: -2.53× (vs Q4'21)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
58.82M
est: 58.80M (+0.0%)
|
65.24M
est: 64.80M (+0.7%)
|
78.06M
est: 75.00M (+4.1%)
|
91.71M
est: 86.00M (+6.6%)
|
144.21M
est: 122.41M (+17.8%)
|
338.40M
est: 271.00M (+24.9%)
|
232.60M
est: 233.65M (-0.5%)
|
101.13M
est: 195.13M (-48.2%)
|
115.21M
est: 211.25M (-45.5%)
|
144.07M
est: 206.60M (-30.3%)
|
| EBITDA |
8.71M
est: 5.38M (+61.9%)
|
4.43M
est: 5.93M (-25.2%)
|
7.25M
est: 6.86M (+5.6%)
|
6.00M
est: 7.86M (-23.7%)
|
22.50M
est: 11.19M (+101.0%)
|
163.04M
est: 24.78M (+557.9%)
|
53.37M
est: 21.37M (+149.8%)
|
-23.97M
est: 17.84M (-234.3%)
|
-3.94M
est: 19.32M (-120.4%)
|
2.47M
est: 18.89M (-86.9%)
|
| EBIT |
7.65M
est: 3.97M (+92.5%)
|
3.07M
est: 4.38M (-29.9%)
|
5.81M
est: 5.06M (+14.6%)
|
4.38M
est: 5.81M (-24.6%)
|
20.04M
est: 8.27M (+142.5%)
|
160.01M
est: 18.30M (+774.3%)
|
49.57M
est: 15.78M (+214.1%)
|
-27.45M
est: 13.18M (-308.3%)
|
-7.81M
est: 14.27M (-154.7%)
|
-1.25M
est: 13.95M (-109.0%)
|
| Net Income |
5.45M
est: 4.97M (+9.7%)
|
2.44M
est: 3.33M (-26.5%)
|
4.34M
est: 4.16M (+4.2%)
|
2.51M
est: 4.16M (-39.7%)
|
13.40M
est: 10.26M (+30.6%)
|
118.77M
est: 106.05M (+12.0%)
|
36.80M
est: 38.68M (-4.9%)
|
-20.73M
est: 24.95M (-183.1%)
|
-6.06M
est: 28.07M (-121.6%)
|
-3.79M
est: 24.95M (-115.2%)
|
| SGA |
8.07M
est: 12.39M (-34.9%)
|
8.36M
est: 13.66M (-38.8%)
|
10.65M
est: 15.80M (-32.6%)
|
15.09M
est: 18.12M (-16.8%)
|
17.72M
est: 25.80M (-31.3%)
|
40.37M
est: 57.11M (-29.3%)
|
33.22M
est: 49.24M (-32.5%)
|
26.57M
est: 41.12M (-35.4%)
|
32.49M
est: 44.52M (-27.0%)
|
35.56M
est: 43.54M (-18.3%)
|
| EPS |
0.01
est: 0.01 (+21.8%)
|
0.00
est: 0.01 (-19.4%)
|
0.01
est: 0.01 (+12.5%)
|
0.00
est: 0.01 (-35.5%)
|
0.02
est: 0.02 (+38.7%)
|
0.19
est: 0.17 (+11.8%)
|
0.06
est: 0.06 (-4.4%)
|
-0.03
est: 0.04 (-183.0%)
|
-0.01
est: 0.05 (-121.6%)
|
-0.01
est: 0.04 (-115.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jun Linn Lee | Chief Operating Officer, Joint Chief Executive Officer & Executive Director | — | male |
| Jun Yih Lee | Finance Director, Joint Chief Executive Officer & Executive Director | — | male |
| Mei Mei Low | Company Secretary | — | female |
| Pek Wee Wong | Managing Director of Manufacturing Division | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 8K7.SI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
